- Brief Report
Biologic Agents in Idiopathic Hypereosinophilic Syndrome
- Ourania Papaioannou,
- Fotios Sampsonas,
- Panagiota Tsiri,
- Vasilina Sotiropoulou,
- Ioannis Christopoulos,
- Dimitrios Komninos and
- Argyrios Tzouvelekis
Background: Hypereosinophilic syndrome (HES) is a heterogeneous group of rare disorders defined by the presence of marked eosinophilia resulting in end organ damage. The diagnostic approach is multidisciplinary and treatment goals include reductions...